GOVX
GOVX
NASDAQ · Biotechnology

Geovax Labs Inc

$1.70
-0.34 (-16.67%)
Financial Highlights (FY 2026)
Revenue
25.36M
Net Income
-218,664,187
Gross Margin
25.0%
Profit Margin
-862.3%
Rev Growth
+212.6%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 25.0% 56.0% 56.0% 56.0%
Operating Margin -869.3% -4.6% -4.4% -3.9%
Profit Margin -862.3% -4.0% -4.1% -4.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 25.36M 586.6K 551.3K 523.6K
Gross Profit 6.34M 328.2K 308.5K 293.0K
Operating Income -220,439,911 -27,171 -24,446 -20,675
Net Income -218,664,187 -23,280 -22,798 -22,545
Gross Margin 25.0% 56.0% 56.0% 56.0%
Operating Margin -869.3% -4.6% -4.4% -3.9%
Profit Margin -862.3% -4.0% -4.1% -4.3%
Rev Growth +212.6% +23.9% +11.9% +23.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 688.2K 727.8K 639.2K
Total Equity — 1.95M 1.96M 1.82M
D/E Ratio — 0.35 0.37 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -219,739,176 -32,929 -31,435 -27,673
Free Cash Flow — -20,426 -16,844 -21,611